Wuhan HealthCare Biotechnology Co., Ltd.H2.C51We are a pioneering biotechnology company dedicated in advancing frontiers in cancer genetic research and diagnostics through cutting-edge solutions consisting of a comprehensive range of Fluorescence In Situ Hybridization (FISH) probes and automation, meticulously designed to streamline laboratories daily process challenges.
At our company, we understand the critical role FISH technology plays in detecting and analyzing genetic abnormalities, especially in the field of oncology & hematology, genetic disorders, and prenatal diagnosis. Our developed FISH probes are precisely crafted with innovative distinctive key features delivering unique benefits.
